| Financial Year |
March 31 2023 |
| Monetary Funds |
182,611,697.04 |
| Held-for-trading Financial Assets |
200,216,956.92 |
| Notes Receivable |
1,251,264.00 |
| Accounts Receivable |
185,523,812.16 |
| Advances to Suppliers |
7,854,809.42 |
| Other Receivables |
13,758,524.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
200,654,515.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,781,951.53 |
| Total Current Assets |
998,774,958.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,238,126.92 |
| Fixed Assetes |
703,544,004.40 |
| Under-construction Projects |
196,217,360.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,288,642.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,498,617.90 |
| Deferred Income Tax Assets |
1,149,100.29 |
| Other Non-Current Assets |
63,537,411.14 |
| Sub-Total of Non-Current Assets |
1,012,359,947.76 |
| Total Assets |
2,011,134,906.46 |
| Short-Term Loans |
60,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
95,509,521.67 |
| Accounts Payable |
184,503,619.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,179,346.28 |
| Taxes Payable |
7,008,993.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,367,461.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
370,213.98 |
| Other Current Liabilities |
708,442.04 |
| Sub-Total of Current Liabilities |
376,097,151.61 |
| Long-term Loans |
-- |
| Bonds Payable |
404,083,060.16 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,367,278.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
437,844,516.48 |
| Total Liabilities |
813,941,668.09 |
| Paid-In Capital(Or Share Stock) |
151,201,975.00 |
| Capital Surplus |
555,629,977.68 |
| Surplus Reserve |
53,370,537.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
412,643,569.92 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,197,193,238.37 |
| Owner's Equity（Stockholder's Equity） |
1,197,193,238.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,011,134,906.46 |
